Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 10,000 shares at $84.81 ($885K) on 2017-06-09, disclosed to the SEC on 2017-06-12.
Open-market sale of $885k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.81 | 400 | $34K | 3.8% |
| 2 | $86.42 | 900 | $78K | 8.8% |
| 3 | $87.80 | 2,502 | $220K | 24.8% |
| 4 | $89.09 | 4,100 | $365K | 41.3% |
| 5 | $89.76 | 1,698 | $152K | 17.2% |
| 6 | $91.08 | 400 |
| $36K |
| 4.1% |
| Total | $88.55 avg | 10,000 | $885K | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-04-27 | $2.5M | — | Filing → |